Mar 27
|
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
|
Mar 25
|
Cintas, UPS, Illumina: Market Minute
|
Mar 25
|
Activist Investor Meister to Join Illumina’s Board
|
Mar 25
|
Illumina shares rise on WSJ report activist investor Meister will join board
|
Mar 25
|
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
|
Mar 25
|
Activist investor Keith Meister to join Illumina's board
|
Mar 24
|
Is Illumina, Inc. (ILMN) the Best Diagnostics Stock to Invest in Right Now?
|
Mar 24
|
Illumina's AGD Project Completes 250,000 Whole Genomes: Stock to Gain?
|
Mar 14
|
JAZZ or ILMN: Which Is the Better Value Stock Right Now?
|
Mar 11
|
Stocks to Watch Tuesday: Tesla, Southwest, Oracle, Illumina
|
Mar 10
|
Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban
|
Mar 10
|
Illumina lowers outlook due to China sales ban, to cut $100 million in costs
|
Mar 10
|
Illumina addresses recent developments in China
|
Mar 10
|
Why Illumina, Inc. (ILMN) Is Plunging So Far In 2025
|
Feb 24
|
ILMN Stock Might Rise From Collaboration With Broad Clinical Labs
|
Feb 24
|
Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology
|
Feb 24
|
Trump’s Early Policy Moves Create New Headaches for This Biotech Heavyweight
|
Feb 21
|
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
|
Feb 20
|
Illumina teases transcriptome profiling tech ahead of 2026 launch
|
Feb 19
|
Cathie Wood Explains AI Growth Catalysts for Illumina (ILMN)
|